"Through the more extensive sequencing that we've done in this study, we can now define the mutations driving the disease in close to 100% of patients." #histiocytosis
In the largest study of its kind led by MSK and published in , researchers found key targetable mutations driving the rare blood disease histiocytosis for nearly all of the people included in the study. Click below to read more.
Histiocytoses are a group of blood diseases that are diagnosed in only a few hundred people in the US per year, but some of the leading experts are right here at MSK. Read about the latest research on causes and possible treatments.
“One of the strengths of this study is that it included all subtypes of #histiocytosis. We have enough data to make these correlations between specific gene mutations and specific forms of histiocytosis.” #RareDiseaseDay